BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 7, 2003
View Archived Issues
Phase I interim safety data reported for Reolysin in malignant glioma
Read More
Results reported for NBI-3001 in glioblastoma
Read More
Cytogen regains rights to ex vivo prostate cancer immunotherapy
Read More
Velcade enters phase II trial in colorectal cancer
Read More
MoliChem reacquires rights to Moli-1901
Read More
AEterna acquires Zentaris from Degussa
Read More
Zindaclin receives further E.U. approvals
Read More
NexMed completes dosing in two-year rat carcinogenicity study
Read More
Crucell regains rights to anti-CD46 antibody
Read More
IND filed for EOS-200-4
Read More
Topamax sNDA submitted for migraine prevention
Read More
Xenova advances two new programs into preclinical research
Read More
Restasis receives FDA approval
Read More
Amylin to acquire rights to Restoragen's GLP-1 program
Read More
Inspra meets primary endpoints in EPHESUS trial
Read More
COX-2-specific inhibitor LAS-34475 compares favorably to naproxen in osteoarthritis
Read More
HDAC inhibitor MS-275 active against pediatric solid tumors in vitro and in vivo
Read More
Third phase III MorphiDex trial fails to meet endpoints
Read More
Pharmacokinetic, toxicity and efficacy data for LEraf-AON in animals
Read More
Highly selective CB2 receptor ligand emerges from SAR studies at U.S. universities
Read More
New central muscle relaxant/antiinflammatory/analgesic advanced to clinical evaluation at GSK
Read More
Novel caspase inhibitors and their use reported by Vertex
Read More
Anticonvulsant compounds in early development at UCB
Read More
Ono patent covers new endothelial differentiation gene-1 (EDG1) agonists
Read More
New JAK3 inhibitors identified at AstraZeneca
Read More
Nonredox antiobesity cobalt porphyrin complexes discovered at MitoKor
Read More
Modified antisense oligonucleotides targeting ICAM-1 and VCAM-1 show potential in IBD
Read More
Galderma describes new series of vitamin D analogues for skin disorders
Read More